Uso de hipoglucemiantes orales en pacientes con diabetes mellitus tipo 2

The data show that OLL treatment for DM2 patients varied from the NOM. Unification of criteria in primary care for the prescription pattern and the use of OLL for better metabolic control of this kind of patient were recommended.